| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/23/2009 | US20090104154 Composition and method for killing of tumours |
| 04/23/2009 | US20090104153 Method of eliciting immune response |
| 04/23/2009 | US20090104151 Smac mimetic dimers and trimers useful as anti-cancer agents |
| 04/23/2009 | US20090104148 Treatment and prevention of joint disease |
| 04/23/2009 | US20090104143 Hyaluronic acid containing bioconjugates: targeted delivery of anti-cancer drugs to cancer cells |
| 04/23/2009 | US20090104142 Compositions for treating multiple sclerosis |
| 04/23/2009 | US20090104132 Topical anti-inflammatory compositions comprising O/W emulsions containing pro-penetrating glycols |
| 04/23/2009 | US20090104131 Topical anti-inflammatory compositions comprising O/W emulsions containing pro-penetrating glycols |
| 04/23/2009 | US20090104127 Suspension aerosol formulations of pharmaceutical products |
| 04/23/2009 | US20090104126 Sulfamate Compounds and Uses Thereof |
| 04/23/2009 | US20090104125 Stable liquid desoximethasone compositions with reduced oxidized impurity |
| 04/23/2009 | US20090104121 Multi-subunit biological complexes for treatment of plaque-associated diseases |
| 04/23/2009 | US20090104119 Dendrimer Based Compositions And Methods Of Using The Same |
| 04/23/2009 | US20090104118 Contrast agents for myocardial perfusion imaging |
| 04/23/2009 | US20090104116 Compounds for the inhibition of integrins and use thereof |
| 04/23/2009 | US20090104114 Nanotherapeutic Colloidal Metal Compositions and Methods |
| 04/23/2009 | DE112004001191T5 Aztreonam L-Lysin und Verfahren für dessen Herstellung Aztreonam L-lysine and method for its preparation |
| 04/23/2009 | DE102008009039A1 Neue Verbindungen aus Antrodia camphorata New compounds from Antrodia camphorata |
| 04/23/2009 | DE102007049451A1 5-Cyano-thienopyridine 5-cyano-thienopyridine |
| 04/23/2009 | DE102007048716A1 Imidazo[1,2-a]pyrimidinderivate Imidazo [1,2-a] pyrimidine derivatives |
| 04/23/2009 | DE102007000521A1 Hustenpräparat Cough preparation |
| 04/23/2009 | CA2806526A1 Trans-clomiphen for type 2 diabetes |
| 04/23/2009 | CA2741094A1 Methods for treatment of thiol-containing compound deficient conditions |
| 04/23/2009 | CA2740882A1 Use of ps20/wfdc1 and interferons to diagnose, monitor and treat viral diseases |
| 04/23/2009 | CA2738834A1 Alpha-amylase inhibitors: the montbretins and uses thereof |
| 04/23/2009 | CA2705414A1 Substituted piperidino-dihydrothienopyrimidines |
| 04/23/2009 | CA2704201A1 Novel sulfated oligosaccharide derivatives |
| 04/23/2009 | CA2703723A1 Inhibitors of anti-apoptotic proteins |
| 04/23/2009 | CA2703720A1 Improved antitumoral treatments |
| 04/23/2009 | CA2703636A1 Amine linked modulators of .gamma.-secretase |
| 04/23/2009 | CA2703615A1 Pharmaceutical compositions for modulating a kinase cascade and methods of use thereof |
| 04/23/2009 | CA2703425A1 Tetrazole derivatives as modulators of metabotropic glutamate receptors (mglurs) |
| 04/23/2009 | CA2703042A1 Formulation to improve gastrointestinal function |
| 04/23/2009 | CA2703039A1 Purine derivatives as adenosine a1 receptor ligands |
| 04/23/2009 | CA2703037A1 Organic compounds |
| 04/23/2009 | CA2703024A1 Improved antitumoral treatments |
| 04/23/2009 | CA2702959A1 Carbon linked modulators of .gamma.-secretase |
| 04/23/2009 | CA2702958A1 Method for producing pyrazole fused ring derivative |
| 04/23/2009 | CA2702950A1 Methods and compounds for modulating cannabinoid activity |
| 04/23/2009 | CA2702946A1 Monoacylglycerol lipase inhibitors for modulation of cannabinoid activity |
| 04/23/2009 | CA2702942A1 Organic compounds |
| 04/23/2009 | CA2702930A1 Maleate salts of (e)-n-{4-[3-chloro-4-(2-pyridinylmethoxy)anilino]-3-cyano-7-ethoxy-6-quinolinyl}-4-(dimethylamino)-2-butenamide and crystalline forms thereof |
| 04/23/2009 | CA2702922A1 Spiro-condensed 1,3,4-thiadiazole derivatives for inhibiting ksp kinesin activity |
| 04/23/2009 | CA2702909A1 Room temperature stable non-crystalline aspirin |
| 04/23/2009 | CA2702903A1 Process for the modification of the solid state of a compound and co-amorphous compositions produced with same |
| 04/23/2009 | CA2702898A1 Inhibitors of c-fms kinase |
| 04/23/2009 | CA2702885A1 Pharmaceutical composition for treatment of cataract |
| 04/23/2009 | CA2702838A1 Thienopyrimidine and pyrazolopyrimidine compounds and their use as mtor kinase and pi3 kinase inhibitors |
| 04/23/2009 | CA2702837A1 Piperidinyl and piperazinyl modulators of .gamma.-secretase |
| 04/23/2009 | CA2702835A1 Amide linked modulators of .gamma.-secretase |
| 04/23/2009 | CA2702834A1 Substituted n-phenyl-pyrrolidinylmethylpyrrolidine amides and therapeutic use thereof |
| 04/23/2009 | CA2702832A1 Biphenyl carboxylic acids and derivatives thereof |
| 04/23/2009 | CA2702805A1 Clioquinol for the treatment of hematological malignancies |
| 04/23/2009 | CA2702745A1 Trisubstituted piperidines |
| 04/23/2009 | CA2702710A1 Trans-clomiphene for metabolic syndrome |
| 04/23/2009 | CA2702699A1 Csf-1r inhibitors compositions, and mthods of use |
| 04/23/2009 | CA2702680A1 Combination analgesic employing opioid and neutral antagonist |
| 04/23/2009 | CA2702674A1 Heteroaryl compounds and uses thereof |
| 04/23/2009 | CA2702664A1 Controlled-release pharmaceutical formulation |
| 04/23/2009 | CA2702644A1 A3 adenosine receptor antagonists |
| 04/23/2009 | CA2702577A1 Method for increasing performance of offspring |
| 04/23/2009 | CA2702563A1 Cgrp antagonists |
| 04/23/2009 | CA2702551A1 5-cyanothienopyridines |
| 04/23/2009 | CA2702524A1 Heterocycle-substituted piperazino-dihydrothienopyrimidines |
| 04/23/2009 | CA2702518A1 New piperazino-dihydrothienopyrimidine derivatives |
| 04/23/2009 | CA2702503A1 Cgrp-antagonists |
| 04/23/2009 | CA2702494A1 Compositions and methods for ameliorating cns inflammation, psychosis, delirium, ptsd or ptss |
| 04/23/2009 | CA2702475A1 Compositions and methods for the treatment of ophthalmic conditions |
| 04/23/2009 | CA2702455A1 Therapeutic agent for trpv1-mediated disease |
| 04/23/2009 | CA2702315A1 Combination 059 |
| 04/23/2009 | CA2702307A1 (r)-4-(heteroaryl) phenylethyl derivatives and pharmaceutical compositions containing them |
| 04/23/2009 | CA2702281A1 Imidazo[1,2-a]pyrimidine derivatives |
| 04/23/2009 | CA2702274A1 2'-flu0r0-2'-deoxytetrahydrouridines as cytidine deaminase inhibitors |
| 04/23/2009 | CA2702039A1 Therapeutic sirna molecules for reducing vegfr1 expression in vitro and in vivo |
| 04/23/2009 | CA2702011A1 Composition for regulating lipid metabolism |
| 04/23/2009 | CA2701953A1 Use of a beta blocker for the manufacture of a medicament for the treatment of hemangiomas |
| 04/23/2009 | CA2701792A1 Calcium receptor modulating agents |
| 04/23/2009 | CA2701037A1 New lipophilic compositions and their uses |
| 04/23/2009 | CA2700910A1 Combination therapy for reducing side effects using cannabinoid receptor ligands |
| 04/23/2009 | CA2700905A1 C7-substituted camptothecin analogs |
| 04/23/2009 | CA2700904A1 C10-substituted camptothecin analogs |
| 04/23/2009 | CA2700729A1 Therapeutic agent for vitiligo and method of accelerating pigmentation |
| 04/23/2009 | CA2700648A1 Quinolizidinone m1 receptor positive allosteric modulators |
| 04/23/2009 | CA2700568A1 Novel sulfamate compounds for medical use |
| 04/23/2009 | CA2700243A1 New no-donor aspirin derivatives |
| 04/23/2009 | CA2699356A1 Crystalline chemotherapeutic |
| 04/23/2009 | CA2699354A1 Crystalline chemotherapeutic |
| 04/23/2009 | CA2699353A1 Crystalline chemotherapeutic |
| 04/23/2009 | CA2699352A1 Crystalline indazole-derived chemotherepeutic |
| 04/23/2009 | CA2699335A1 Solid dispersion product containing n-aryl urea-based compound |
| 04/23/2009 | CA2699302A1 Crystalline chemotherapeutic |
| 04/23/2009 | CA2699301A1 Solid dispersion product of n-aryl urea-based drugs |
| 04/23/2009 | CA2697982A1 1,3,5-trisubstituted triazole derivative |
| 04/23/2009 | CA2697974A1 Trisubstituted 1,2,4-triazoles |
| 04/23/2009 | CA2696984A1 Improved pharmaceutical composition containing a selective estrogen receptor modulator and method for the preparation thereof |
| 04/23/2009 | CA2694994A1 Tricyclic n-heteroaryl-carboxamide derivatives, preparation thereof and therapeutic use of same |
| 04/23/2009 | CA2694377A1 Imidazolone derivatives, preparation method thereof and biological use of same |
| 04/23/2009 | CA2690732A1 Rnai mediated knockdown of numa for cancer therapy |
| 04/23/2009 | CA2678092A1 Bilayer composition for the sustained release of acetaminophen and tramadol |
| 04/22/2009 | EP2050815A1 Streptomyces Avermitilis gene directing the ratio of B2:B1 avermectins |